The role of FoxO in the regulation of metabolism
暂无分享,去创建一个
M. Birnbaum | D. N. Gross | A. Heuvel | M J Birnbaum | D N Gross | A P J van den Heuvel | D. Gross | M. Birnbaum | DN Gross | Apj van den Heuvel | D N Gross | A P J van den Heuvel | M J Birnbaum | DN Gross | Apj van den Heuvel | MJ Birnbaum
[1] Guillaume Adelmant,et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.
[2] K. Kaestner,et al. Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. , 2002, Diabetes.
[3] L. Guarente,et al. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans , 2001, Nature.
[4] V. Grill,et al. Overstimulation and beta-cell function. , 2001, Diabetes.
[5] Mark D. Johnson,et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.
[6] R. Nusse,et al. Wnt signaling regulates pancreatic β cell proliferation , 2007, Proceedings of the National Academy of Sciences.
[7] Steven P Gygi,et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.
[8] J. Flier,et al. Adipose Tissue as an Endocrine Organ , 2014 .
[9] M. Primig,et al. Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. , 2000, Molecular biology of the cell.
[10] M. Prentki,et al. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells , 1999, Diabetologia.
[11] R. Mattingly,et al. High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis , 2002, The Journal of cell biology.
[12] S. G. Rønn,et al. Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. , 2005, Journal of molecular endocrinology.
[13] H. Kaneto,et al. Crucial role of PDX-1 in pancreas development, beta-cell differentiation, and induction of surrogate beta-cells. , 2007, Current medicinal chemistry.
[14] H. Kiyonari,et al. Forkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure , 2008, Diabetes.
[15] D. Accili,et al. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.
[16] J. Habener,et al. Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation* , 2008, Journal of Biological Chemistry.
[17] Jie Chen,et al. The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent Mechanism* , 2001, The Journal of Biological Chemistry.
[18] A. Russell,et al. Akt signalling through GSK‐3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy , 2006, The Journal of physiology.
[19] L. Sussel,et al. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] D. Allen,et al. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors , 2007 .
[22] D. Accili,et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.
[23] M. Stoffel,et al. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. , 2002, Nature genetics.
[24] T. Hunter,et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Munday,et al. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. , 1998, Diabetes.
[26] Sunmin Park,et al. Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. , 2006, The Journal of biological chemistry.
[27] J. Altomonte,et al. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. , 2007, American journal of physiology. Endocrinology and metabolism.
[28] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Wilson,et al. Selective Control of Skeletal Muscle Differentiation by Akt1* , 2007, Journal of Biological Chemistry.
[30] M. LaDu,et al. Regulation of lipoprotein lipase in adipose and muscle tissues during fasting. , 1991, The American journal of physiology.
[31] R. Morrison,et al. Hormonal signaling and transcriptional control of adipocyte differentiation. , 2000, The Journal of nutrition.
[32] R A Roth,et al. Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. , 2001, Biochemical and biophysical research communications.
[33] A. Lombardi,et al. Fuel economy in food‐deprived skeletal muscle: signaling pathways and regulatory mechanisms , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] Miki Suzuki,et al. A forkhead transcription factor FKHR up‐regulates lipoprotein lipase expression in skeletal muscle , 2003, FEBS letters.
[35] K. Kaestner,et al. Winged-helix transcription factors and pancreatic development. , 2005, Clinical science.
[36] J. Girard,et al. Role of the liver in the control of carbohydrate and lipid homeostasis. , 2004, Diabetes & metabolism.
[37] D. Accili,et al. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. , 2006, The Journal of clinical investigation.
[38] M. Boylan,et al. Glucose-Dependent Insulinotropic Polypeptide (GIP) , 1999 .
[39] R. Ajisaka,et al. The regulation of adiponectin receptors expression by acute exercise in mice. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[40] R. DePinho,et al. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.
[41] G. Shulman,et al. Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action , 2006, Diabetes.
[42] A. Russell,et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin‐1 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] P. J. Randle. Fuel selection in animals. , 1986, Biochemical Society transactions.
[44] C. Kahn,et al. Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.
[45] E. Cerasi,et al. A pancreatic beta -cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta ), HNF-1alpha, and SPs transcription factors. , 2001, The Journal of biological chemistry.
[46] Bruce M. Spiegelman,et al. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.
[47] O. MacDougald,et al. Adipocyte differentiation from the inside out , 2006, Nature Reviews Molecular Cell Biology.
[48] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[49] W. Mitch,et al. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. , 2004, Journal of the American Society of Nephrology : JASN.
[50] K. Esser,et al. FoxO1 Stimulates Fatty Acid Uptake and Oxidation in Muscle Cells through CD36-dependent and -independent Mechanisms* , 2005, Journal of Biological Chemistry.
[51] R. DePinho,et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. , 2007, The Journal of clinical investigation.
[52] A. Fukamizu,et al. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. , 2006, The Journal of clinical investigation.
[53] T. Jin. The WNT signalling pathway and diabetes mellitus , 2008, Diabetologia.
[54] Peter Tontonoz,et al. Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X Receptors* , 2002, The Journal of Biological Chemistry.
[55] N. Motoyama,et al. FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. , 2005, Antioxidants & redox signaling.
[56] C. Kahn,et al. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. , 2007, Cell metabolism.
[57] R. Stein,et al. Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene , 1997, Molecular and cellular biology.
[58] M. McVey,et al. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. , 1999, Genes & development.
[59] Hui Chen,et al. FOXO1 Represses Peroxisome Proliferator-activated Receptor-γ1 and -γ2 Gene Promoters in Primary Adipocytes , 2006, Journal of Biological Chemistry.
[60] 土田 敦之. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity , 2005 .
[61] G. Sharp,et al. Glucose‐stimulated signaling pathways in biphasic insulin secretion , 2002, Diabetes/metabolism research and reviews.
[62] Jinfei Xu,et al. Protein Kinase B/AKT 1 Plays a Pivotal Role in Insulin-like Growth Factor-1 Receptor Signaling Induced 3T3-L1 Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.
[63] W. Mitch,et al. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. , 2006, Endocrinology.
[64] A. Hevener,et al. PPARdelta regulates glucose metabolism and insulin sensitivity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[65] F. Booth,et al. Age-dependent FOXO regulation of p27Kip1 expression via a conserved binding motif in rat muscle precursor cells. , 2008, American journal of physiology. Cell physiology.
[66] S. Farmer. Regulation of PPARgamma activity during adipogenesis. , 2005, International journal of obesity.
[67] V. Large,et al. Metabolism of lipids in human white adipocyte. , 2004, Diabetes & metabolism.
[68] M. Palacín,et al. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. , 1998, Molecular endocrinology.
[69] V. Grill,et al. Short-term intermittent exposure to diazoxide improves functional performance of beta-cells in a high-glucose environment. , 2004, American journal of physiology. Endocrinology and metabolism.
[70] K. Guan,et al. Negative Regulation of the Forkhead Transcription Factor FKHR by Akt* , 1999, The Journal of Biological Chemistry.
[71] B. Spiegelman,et al. Molecular regulation of adipogenesis. , 2000, Annual review of cell and developmental biology.
[72] B. Hemmings,et al. PKBα is required for adipose differentiation of mouse embryonic fibroblasts , 2006, Journal of Cell Science.
[73] M. Matsuda,et al. Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. , 2002, Diabetes.
[74] Ying-Chu Lee,et al. STAT5 Activity in Pancreatic β-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes , 2006, Diabetes.
[75] P. Vogt,et al. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[76] O. Chepurny,et al. Diabetes Outfoxed by GLP-1? , 2005, Science's STKE.
[77] R. Tjian,et al. Codependent activators direct myoblast-specific MyoD transcription. , 2008, Developmental cell.
[78] M. Lane,et al. Mitotic clonal expansion: A synchronous process required for adipogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. Kushner,et al. Pdx1 restores β cell function in Irs2 knockout mice , 2002 .
[80] R. O’Brien,et al. Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin , 2000, The Journal of Biological Chemistry.
[81] A. Brunet,et al. FoxO transcription factors in the maintenance of cellular homeostasis during aging. , 2008, Current opinion in cell biology.
[82] T. Noda,et al. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. , 2008, Cell metabolism.
[83] T. Fielder,et al. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. , 2003, American journal of physiology. Endocrinology and metabolism.
[84] B. Spiegelman,et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.
[85] D. Accili,et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.
[86] Jerrold M. Olefsky,et al. PPARδ regulates glucose metabolism and insulin sensitivity , 2006 .
[87] M. Febbraio,et al. FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle* , 2007, Journal of Biological Chemistry.
[88] L. N. Valenti,et al. Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes* , 2005, Journal of Biological Chemistry.
[89] A. Goldberg,et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[90] Xueying Lin,et al. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. , 2006, The Journal of clinical investigation.
[91] D. Glass. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy , 2003, Nature Cell Biology.
[92] P. Cohen,et al. Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.
[93] R. Evans,et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. , 2003, Cell.
[94] J. Altomonte,et al. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. , 2006, Endocrinology.
[95] C. Mcintosh,et al. Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression* , 2005, Journal of Biological Chemistry.
[96] D. Accili,et al. Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic β-Cell Mass , 2006, Diabetes.
[97] B. Burgering,et al. Cell cycle and death control: long live Forkheads. , 2002, Trends in biochemical sciences.
[98] J. Egan,et al. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. , 1999, Endocrinology.
[99] J. Auwerx,et al. E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.
[100] Jourdan J. Pouliot,et al. development and , 2019 .
[101] S. Mandrup,et al. Regulating Adipogenesis* , 1997, The Journal of Biological Chemistry.
[102] Satoko Aratani,et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[103] P. Puigserver,et al. Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[104] M. Meseck,et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. , 2008, The Journal of clinical investigation.
[105] Philippe Lefebvre,et al. Sorting out the roles of PPARα in energy metabolism and vascular homeostasis , 2006 .
[106] M. Stoffel,et al. Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[107] R. Silverstein,et al. Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice* , 2000, The Journal of Biological Chemistry.
[108] J. Altomonte,et al. PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1 , 2007 .
[109] R. Robertson,et al. Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. , 2002, Endocrinology.
[110] T. Kitamura,et al. Role of FoxO Proteins in Pancreatic β Cells , 2007 .
[111] W. Pang,et al. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes , 2007, Molecular and Cellular Biochemistry.
[112] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[113] Q. Tong,et al. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. , 2008, Molecular biology of the cell.
[114] A. F. Stewart,et al. Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia* , 2000, The Journal of Biological Chemistry.
[115] M. Lane,et al. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. , 2003, The Journal of biological chemistry.
[116] G. Shulman,et al. Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.
[117] A. Fukamizu,et al. Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development , 2007, The EMBO journal.
[118] S. Bonner-Weir,et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. , 2000, Diabetes.
[119] R. Robertson,et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. , 2004, Diabetes.
[120] P. Puigserver,et al. O-GlcNAc Regulates FoxO Activation in Response to Glucose* , 2008, Journal of Biological Chemistry.
[121] A. Fukamizu,et al. Hepatocyte Nuclear Factor-4 Is a Novel Downstream Target of Insulin via FKHR as a Signal-regulated Transcriptional Inhibitor* , 2003, The Journal of Biological Chemistry.
[122] J. Shaw,et al. Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[123] P. Puigserver,et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[124] C. Burant,et al. Role of FoxO1 in FFA-induced oxidative stress in adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.
[125] P. Rotwein,et al. Insulin-like Growth Factor-mediated Muscle Differentiation , 2001, The Journal of Biological Chemistry.
[126] I. Rooman,et al. Regulation of pancreatic beta-cell mass. , 2005, Physiological reviews.
[127] S. Bodine,et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. , 2008, American journal of physiology. Endocrinology and metabolism.
[128] J. Gustafsson,et al. Liver X Receptors as Insulin-mediating Factors in Fatty Acid and Cholesterol Biosynthesis* , 2002, The Journal of Biological Chemistry.
[129] D. Accili,et al. Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[130] J. Holloszy,et al. Exercise induces lipoprotein lipase and GLUT-4 protein in muscle independent of adrenergic-receptor signaling. , 2000, Journal of applied physiology.
[131] S. Aizawa,et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.
[132] M. Foretz,et al. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[133] K. M. Popov,et al. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. , 1998, The Biochemical journal.
[134] G. Heigenhauser,et al. Human skeletal muscle PDH kinase activity and isoform expression during a 3-day high-fat/low-carbohydrate diet. , 2001, American journal of physiology. Endocrinology and metabolism.
[135] S. G. Rønn,et al. Regulation of pancreatic β-cell mass and proliferation by SOCS-3 , 2005 .
[136] M. Birnbaum,et al. When the usual insulin is just not enough , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[137] Y. Terauchi,et al. Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation , 2001, Molecular and Cellular Biology.
[138] B. Spiegelman,et al. PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .
[139] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[140] T. Furuyama,et al. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. , 2003, The Biochemical journal.
[141] S. McKnight,et al. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. , 1995, Genes & development.
[142] S. Farmer,et al. Regulation of PPARγ activity during adipogenesis , 2005, International Journal of Obesity.
[143] D. Accili,et al. Regulation of insulin-like growth factor–dependent myoblast differentiation by Foxo forkhead transcription factors , 2003, The Journal of cell biology.
[144] A. Bradley,et al. Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.
[145] C. Kahn,et al. Differential Roles of Insulin Receptor Substrates in Brown Adipocyte Differentiation , 2004, Molecular and Cellular Biology.
[146] Z. Wu,et al. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.
[147] A. Husch,et al. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. , 2008, Cell metabolism.
[148] B. Hemmings,et al. PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts. , 2006, Journal of cell science.
[149] H. Kaneto,et al. Crucial Role of PDX-1 in Pancreas Development, β-Cell Differentiation, and Induction of Surrogate β-Cells , 2007 .
[150] P. Kelly,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance , 2022 .
[151] Robert A. Harris,et al. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. , 2004, Diabetes.
[152] M. Febbraio,et al. PGC‐1α gene expression is down‐regulated by Akt‐mediated phosphorylation and nuclear exclusion of FoxO1 in insulin‐stimulated skeletal muscle , 2005, The FASEB Journal.
[153] B. Lamothe,et al. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. , 1996, The EMBO journal.
[154] Jerry Donovan,et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. , 2003, Nature.
[155] F. Hansmannel,et al. Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor. , 2006, The Biochemical journal.
[156] Y. Kido,et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. , 2000, The Journal of clinical investigation.
[157] G. Barsh,et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake , 2006, Nature Medicine.
[158] D. Cameron-Smith,et al. Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting. , 2004, Journal of applied physiology.
[159] Marc Montminy,et al. TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver , 2003, Science.
[160] F. Foufelle,et al. SREBP transcription factors: master regulators of lipid homeostasis. , 2004, Biochimie.
[161] Chun Li Zhang,et al. Signaling chromatin to make muscle. , 2002, Current opinion in cell biology.
[162] N. Sonenberg,et al. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice , 1996, Molecular and cellular biology.
[163] B. Staels,et al. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. , 2006, The Journal of clinical investigation.
[164] L. C. Murtaugh,et al. Pancreas and beta-cell development: from the actual to the possible , 2006, Development.
[165] J. Xu,et al. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. , 2004, The Journal of clinical investigation.
[166] J. Kushner,et al. Phosphatase and Tensin Homolog Regulation of Islet Growth and Glucose Homeostasis* , 2005, Journal of Biological Chemistry.
[167] R. Evans,et al. Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.
[168] B. Lowell,et al. Monitoring FoxO1 Localization in Chemically Identified Neurons , 2008, The Journal of Neuroscience.
[169] Namjin Chung,et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ , 2004, Nature.
[170] A. Goldberg,et al. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.
[171] H. Kaneto,et al. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. , 2003, Diabetes.
[172] Y. Chen,et al. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. , 1996, Genes & development.
[173] M. Montminy,et al. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.
[174] M. Benito,et al. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-κB through an AKT/P70S6K/p38-MAPK pathway , 2002, Oncogene.
[175] P. Vogt,et al. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[176] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[177] Robert A. Harris,et al. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. , 2002, Diabetes.
[178] Min-Seon Kim,et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.
[179] J. McGarry,et al. The glucose paradox. Is glucose a substrate for liver metabolism? , 1984, The Journal of clinical investigation.
[180] J. Florini,et al. The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.
[181] Hendrik C Korswagen,et al. Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling , 2005, Science.
[182] J. Yates,et al. A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange , 2008, Nature.
[183] Sunmin Park,et al. Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function* , 2006, Journal of Biological Chemistry.
[184] J. Bos,et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK , 2004, The EMBO journal.
[185] I. Kii,et al. Inactivation of Rho/ROCK Signaling Is Crucial for the Nuclear Accumulation of FKHR and Myoblast Fusion* , 2004, Journal of Biological Chemistry.
[186] R. DePinho,et al. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.
[187] H. Kaneto,et al. Oxidative Stress Induces Nucleo-Cytoplasmic Translocation of Pancreatic Transcription Factor PDX-1 Through Activation of c-Jun NH2-terminal Kinase , 2003 .
[188] M. Essers,et al. Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity* , 2008, Journal of Biological Chemistry.
[189] C. Kahn,et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.
[190] M. Imae,et al. Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. , 2003, Journal of molecular endocrinology.
[191] G. Grosveld,et al. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts , 2003, The EMBO journal.
[192] T. Yagi,et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.
[193] E. Hietanen,et al. Adipose, Muscle and Lung Tissue Lipoprotein Lipase Activities in Young Streptozotocin Treated Rats , 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[194] M. Birnbaum,et al. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator , 2007, Nature.
[195] T. Unterman,et al. FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. , 2005, Biochemical and biophysical research communications.
[196] P. Puigserver,et al. A PGC-1α-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose* , 2009, Journal of Biological Chemistry.
[197] I. Goldberg. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.
[198] In-kyu Lee,et al. SREBP-1c Mediates the Insulin-dependent Hepatic Glucokinase Expression* , 2004, Journal of Biological Chemistry.
[199] P. Butler,et al. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose. , 2004, The Journal of clinical endocrinology and metabolism.
[200] C. Mounier,et al. Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins. , 2006, Endocrinology.
[201] P. Puigserver,et al. Transcriptional regulation of adipogenesis. , 2000, Genes & development.
[202] N. Abumrad,et al. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. , 2002, Annual review of nutrition.
[203] I. Macdonald,et al. Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans , 2006, The Journal of physiology.
[204] P. Neufer,et al. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. , 2000, American journal of physiology. Endocrinology and metabolism.
[205] E. Van Obberghen,et al. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. , 2007, Endocrinology.
[206] R. Robertson,et al. Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. , 2002, Endocrinology.
[207] A. Goldberg,et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.
[208] T. Unterman,et al. The Transcription Factors HIF-1 and HNF-4 and the Coactivator p300 Are Involved in Insulin-regulated Glucokinase Gene Expression via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway* , 2004, Journal of Biological Chemistry.
[209] D. Accili,et al. FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.
[210] A. Fukamizu,et al. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. , 2003, Diabetes.
[211] Y. Kido,et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. , 2002, The Journal of clinical investigation.
[212] B. Teusink,et al. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. , 2005, Diabetes.
[213] S. Marklund,et al. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. , 1981, The Biochemical journal.
[214] A. Bonen,et al. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.
[215] Johannes D. Veldhuis,et al. Induction of β-cell rest by a Kir6.2/SUR1-selective KATP-Channel opener preserves β-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose , 2004 .
[216] C. Newgard,et al. Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.
[217] K. Kaestner,et al. Foxa2 Controls Pdx1 Gene Expression in Pancreatic β-Cells In Vivo , 2002 .
[218] B. Emanuel,et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.
[219] E. Greer,et al. FOXO transcription factors at the interface between longevity and tumor suppression , 2005, Oncogene.
[220] D. Accili,et al. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.
[221] C. Kahn,et al. Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.
[222] J. Kushner,et al. Pdx1 restores beta cell function in Irs2 knockout mice. , 2002, The Journal of clinical investigation.
[223] S. Bonner-Weir,et al. Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression* , 2002, The Journal of Biological Chemistry.
[224] Se-Jin Lee,et al. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.
[225] R. Robertson,et al. β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes , 2004 .
[226] R. Morrison,et al. Role of PPARγ in Regulating a Cascade Expression of Cyclin-dependent Kinase Inhibitors, p18(INK4c) and p21(Waf1/Cip1), during Adipogenesis* , 1999, The Journal of Biological Chemistry.
[227] P. Neufer,et al. Effect of short-term fasting and refeeding on transcriptional regulation of metabolic genes in human skeletal muscle. , 2003, Diabetes.
[228] Marc Montminy,et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.
[229] Jeong-Ho Kim,et al. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. , 2008, Endocrinology.
[230] J. Breslow,et al. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. , 1990, Science.
[231] M. Lane,et al. Convergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways* , 2003, Journal of Biological Chemistry.
[232] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[233] H. Kaneto,et al. The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation* , 2006, Journal of Biological Chemistry.
[234] Dominique A. Glauser,et al. The emerging role of FOXO transcription factors in pancreatic beta cells. , 2007, The Journal of endocrinology.
[235] T. Kitamura,et al. Role of FoxO Proteins in Pancreatic beta Cells. , 2007, Endocrine journal.
[236] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[237] M. Stoffel,et al. β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.
[238] Hiroyuki Aburatani,et al. Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.
[239] K. Heidenreich,et al. FoxO1 Regulates Multiple Metabolic Pathways in the Liver , 2006, Journal of Biological Chemistry.
[240] Hui Chen,et al. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. , 2006, The Journal of biological chemistry.